(Q36455870)

14 August 2017

1 reference

title

Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma (English)

1 reference

14 August 2017

0 references

Buhl R

1

1 reference

14 August 2017

publication date

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

61

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

518-526

1 reference

Treatment of allergic asthma

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Environmental contributions to the allergic asthma epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

The global burden of asthma: executive summary of the GINA Dissemination Committee report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Potential adverse effects of the inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

The local side effects of inhaled corticosteroids: current understanding and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Pharmacokinetics and pharmacodynamics of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

The influence of lung deposition on clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Spacer devices for metered dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Inhalational and topical steroids, and oral candidosis: a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Beclomethasone dipropionate aerosol and oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Efficacy and safety of inhaled corticosteroids. New developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Effects of amphotericin B gargles on oral colonization of Candida albicans in asthmatic patients on steroid inhalation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Ciclesonide: a novel inhaled corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

Chlorofluorocarbon-free inhalers: are we ready for the change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01090.X

10.1111/J.1398-9995.2006.01090.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference